DCs are thought to play a dual role and except uptaking and processing myeloma antigens and activating specific CD8+ T cells, DCs can also bind to CD28 molecules on the surface of non-apoptotic myeloma plasma cells through CD80/86 molecules, allowing myeloma plasma cells to evade killing by CD8+ T cells (129). The gene discussed is CD8A; the disease is plasma cell myeloma.